@winifredfs
Gene editing technology, particularly CRISPR-Cas9, offers promising prospects for treating genetic disorders by enabling precise modification of defective genes. Clinical trials are underway targeting diseases like sickle cell anemia, cystic fibrosis, anr dystrophy. The act mutations at the DNA level opens possibilities for long-term curesmptom managememain regarding off-target effects, delivery mechanisms, and ethical concerns, but advancements in gene therapy continue to push toward safe, effective, and personalized treatments that could revolutionize medicine for hereditary diseases.